Kezar Life Sciences, Inc. SEC Filings

Filed On	Filing
28 May 2026	SCHEDULE 13G/A
21 May 2026	15-12G
14 May 2026	EFFECT
13 May 2026	SCHEDULE 13D/A
12 May 2026	SCHEDULE 13G/A
12 May 2026	SCHEDULE 13G/A
11 May 2026	Form 4: Wallace Courtney, Director Disposed of 21,300 Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Schiller Mark C., Chief Operating Officer Disposed of 2,739 shares (Tender Offer) · Disposed of 114,745 Employee Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Klearman Micki, Director Disposed of 23,900 Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Kirk Christopher J., Director Disposed of 43,134 shares (Tender Offer) · Disposed of 328,997 Employee Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Kauffman Michael, Director Disposed of 6,369 shares (Tender Offer) · Disposed of 20,867 Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Cooper Graham K, Director Disposed of 27,709 Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Garner Elizabeth, Director Disposed of 21,368 Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Berger Franklin M, Director Disposed of 89,069 shares (Tender Offer) · Disposed of 18,700 Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Fowler John Franklin, Director Disposed of 43,611 shares (Tender Offer) · Disposed of 329,317 Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Belsky Marc, Chief Financial Officer Disposed of 1,738 shares (Tender Offer) · Disposed of 160,286 Employee Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	Form 4: Chiang Pichi Luo, SVP, Corporate Controller Disposed of 2,711 shares (Tender Offer) · Disposed of 75,046 Employee Stock Option (right to buy) (Disposition to Issuer)
11 May 2026	S-8 POS
11 May 2026	S-8 POS
11 May 2026	S-8 POS

Comments